Update on FDA Priority Review of Dupixent® for the Treatment of COPD Patients with Type 2 Inflammation 31 May 2024
Biohaven Doses First Patient with its Novel Trop-2 Directed Antibody Drug Conjugate BHV-1510 in Advanced or Metastatic Epithelial Tumors 29 May 2024
